Functional Specialization of Interleukin-17 Family Members

Laboratory of Molecular Pathogenesis, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, Japan.
Immunity (Impact Factor: 21.56). 02/2011; 34(2):149-62. DOI: 10.1016/j.immuni.2011.02.012
Source: PubMed


Interleukin-17A (IL-17A) is the signature cytokine of the recently identified T helper 17 (Th17) cell subset. IL-17 has six family members (IL-17A to IL-17F). Although IL-17A and IL-17F share the highest amino acid sequence homology, they perform distinct functions; IL-17A is involved in the development of autoimmunity, inflammation, and tumors, and also plays important roles in the host defenses against bacterial and fungal infections, whereas IL-17F is mainly involved in mucosal host defense mechanisms. IL-17E (IL-25) is an amplifier of Th2 immune responses. The functions of IL-17B, IL-17C, and IL-17D remain largely elusive. In this review, we describe the identified functions of each IL-17 family member and discuss the potential of these molecules as therapeutic targets.

Download full-text


Available from: Yoichiro Iwakura, Oct 09, 2015
1 Follower
303 Reads
  • Source
    • "endent manner ( Stoolman et al . , 2014 ) . In classical EAE in WT mice , CCL2 was increased in the spinal cord driving the recruitment of monocytes / macrophages in a partially CCR2 - dependent manner ( Stoolman et al . , 2014 ) . Given that IL - 17 induces CXCL2 the conclusion that atypical EAE was IL - 17 - independent is an important finding ( Iwakura et al . , 2011 ; Stoolman et al . , 2014 ) . In the Goverman study using C3HeB / FeJ mice deficient in either IFNGR or IL - 17RA , it was shown that IL - 17 promoted ELR + CXC chemokine - mediated recruitment of neutrophils into the brain while IFN - γ inhibited ELR + CXC chemokine and neutrophil production in the brain , but had the converse effect i"
    [Show abstract] [Hide abstract]
    ABSTRACT: Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) mediated by T helper (h)1 and/or Th17 CD4 T cells that drive inflammatory lesion development along with demyelination and neuronal damage. Defects in immune regulatory mechanisms are thought to play a role in the pathogenesis of MS. While an early clinical trial indicated that IFN-γ administration was detrimental to MS, studies in the mouse model of MS, experimental autoimmune encephalomyelitis (EAE), indicated that IFN-γ exhibits a number of anti-inflammatory properties within the CNS. These mechanisms include inhibition of IL-17 production, induction of regulatory T cells, T cell apoptosis and regulation of chemokine production. Mice deficient in IFN-γ or its receptor were instrumental in deciphering the anti-inflammatory properties of IFN-γ in the CNS. In particular, they revealed that IFN-γ is a major regulator of neutrophil recruitment into the CNS, which by a variety of mechanisms including disruption of the blood-brain-barrier (BBB) and production of reactive oxygen species are thought to contribute to the onset and progression of EAE. Neutrophils were also shown to be instrumental in EAE relapses. To date neutrophils have not been appreciated as a driver of MS, but more recently based largely on strong EAE data this view is being reevaluated by some investigators in the field.
    Frontiers in Neuroscience 09/2015; 9:287. DOI:10.3389/fnins.2015.00287 · 3.66 Impact Factor
  • Source
    • "Our data may shed some light on the mechanisms behind the strong therapeutic effects of hMSC therapy on related diseases (Bassi et al., 2012; Sun et al., 2009; Zhou et al., 2011) and implicate a role for IL-25 agonists in ameliorating autoimmune/inflammatory diseases as well as transplant rejection. IL-25 (IL-17E) is a member of the IL-17 family (Iwakura et al., 2011). However, unlike IL-17A or F, the better-known members of this IL family that have direct roles in autoimmune and chronic inflammatory diseases, IL-25 actually appears to protect against IL-17A/Th17 and Th1 states (Caruso et al., 2009a). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Multipotent human mesenchymal stromal cells (hMSCs) harbor immunomodulatory properties that are therapeutically relevant. One of the most clinically important populations of leukocytes is the interleukin-17A (IL-17A)-secreting T (Th17) lymphocytes. However, mechanisms of hMSC and Th17 cell interactions are incompletely resolved. We found that, along with Th1 responses, hMSCs strongly suppressed Th17 responses and this required both IL-25-also known as IL-17E-as well as programmed death ligand-1 (PD-L1), a potent cell surface ligand for tolerance induction. Knockdown of IL-25 expression in hMSCs abrogated Th17 suppression in vitro and in vivo. However, IL-25 alone was insufficient to significantly suppress Th17 responses, which also required surface PD-L1 expression. Critically, IL-25 upregulated PD-L1 surface expression through the signaling pathways of JNK and STAT3, with STAT3 found to constitutively occupy the proximal region of the PD-L1 promoter. Our findings demonstrate the complexities of hMSC-mediated Th17 suppression, and highlight the IL-25/STAT3/PD-L1 axis as a candidate therapeutic target. Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.
    Stem Cell Reports 08/2015; DOI:10.1016/j.stemcr.2015.07.013 · 5.37 Impact Factor
  • Source
    • "Of relevance, interleukin-17A (IL-17A) promotes G-CSF-and stem-cell-factor-mediated neutrophilia (Liu et al., 2010) and supports G-CSF-driven ''emergency'' myelopoiesis (Schwarzenberger et al., 2000). Despite the fact that IL-17 expression in cancer has been so far mainly restricted to the adaptive immunity (Iwakura et al., 2011) and its role in cancer remains controversial (Toomer and Chen, 2014), TAMs and MDSCs produce the Th17-driving cytokines TGFb and IL-6 (Zamarron and Chen, 2011), and IL- 17-expressing cells with macrophage morphology have been described in cancer patients (Zhu et al., 2008). Although the Th17 response is controlled by the orphan nuclear receptor retinoic-acid-related orphan receptor gamma (RORg) full-length protein (RORC1) and the RORCgt splice variant (RORC2) (Ivanov et al., 2006), the signaling pathways that drive IL-17-producing innate immune cells have been poorly investigated. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cancer-driven granulo-monocytopoiesis stimulates expansion of tumor promoting myeloid populations, mostly myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs). We identified subsets of MDSCs and TAMs based on the expression of retinoic-acid-related orphan receptor (RORC1/RORγ) in human and mouse tumor bearers. RORC1 orchestrates myelopoiesis by suppressing negative (Socs3 and Bcl3) and promoting positive (C/EBPβ) regulators of granulopoiesis, as well as the key transcriptional mediators of myeloid progenitor commitment and differentiation to the monocytic/macrophage lineage (IRF8 and PU.1). RORC1 supported tumor-promoting innate immunity by protecting MDSCs from apoptosis, mediating TAM differentiation and M2 polarization, and limiting tumor infiltration by mature neutrophils. Accordingly, ablation of RORC1 in the hematopoietic compartment prevented cancer-driven myelopoiesis, resulting in inhibition of tumor growth and metastasis. Copyright © 2015 Elsevier Inc. All rights reserved.
    Cancer cell 08/2015; 28(2):253-69. DOI:10.1016/j.ccell.2015.07.006 · 23.52 Impact Factor
Show more